Signal Advisors Wealth LLC Grows Position in Intuitive Surgical, Inc. $ISRG

Signal Advisors Wealth LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 99.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,697 shares of the medical equipment provider’s stock after acquiring an additional 3,337 shares during the period. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $2,995,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares in the last quarter. Capital Analysts LLC grew its holdings in Intuitive Surgical by 12.1% during the 1st quarter. Capital Analysts LLC now owns 427 shares of the medical equipment provider’s stock valued at $212,000 after buying an additional 46 shares in the last quarter. Martingale Asset Management L P bought a new stake in Intuitive Surgical in the 1st quarter worth approximately $2,041,000. Compound Planning Inc. increased its stake in Intuitive Surgical by 77.5% in the 1st quarter. Compound Planning Inc. now owns 4,149 shares of the medical equipment provider’s stock worth $2,055,000 after acquiring an additional 1,812 shares during the last quarter. Finally, D.B. Root & Company LLC raised its holdings in shares of Intuitive Surgical by 8.6% during the 1st quarter. D.B. Root & Company LLC now owns 847 shares of the medical equipment provider’s stock worth $419,000 after acquiring an additional 67 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Sanford C. Bernstein restated an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. BTIG Research upped their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Jefferies Financial Group lifted their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $611.08.

Insider Activity

In related news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at $193,595.79. This trade represents a 95.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by corporate insiders.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Intuitive Surgical Trading Up 1.9%

Shares of ISRG opened at $572.47 on Friday. The company’s fifty day simple moving average is $541.48 and its 200-day simple moving average is $506.30. The company has a market cap of $205.22 billion, a P/E ratio of 75.72, a P/E/G ratio of 5.16 and a beta of 1.68. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the firm posted $1.84 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.